MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*”Architects”: Geriatrics, Gerontology, Geroscience, Longevity, Healthspan & Aging
LyGenesis, Inc.*
Organization & Developments: LyGenesis
Parents
LyGenesis, Inc.*
Children
*Cell therapies completely upend the economics and supply-demand calculus of organ transplantation by using the patient’s own lymph nodes as bioreactors to grow functioning ectopic organs
*Cell therapy technology designed to facilitate organ regeneration and transplant.
*Focused on liver regeneration for patients with end-stage liver disease which uses lymph nodes as bioreactors and outpatient endoscopic ultrasound for transplantation of donor cells
*LyGenesis, Inc. is a clinical-stage cell therapy company that transforms a patient’s lymph nodes into bioreactors capable of growing functioning ectopic organs.
*Technology for organ regeneration to treat end-stage disease.
2022: Startup wants to regrow livers in humans, and it could transform organ donation
2024: ‘Mini liver’ will grow in person’s own lymph node in bold new trial
2024: LyGenesis Announces First Patient Dosed in its Phase 2a Clinical Trial of a First-in-Class Regenerative Cell Therapy for Patients with End-Stage Liver Disease
Jumps
Finance & Acquisitions: LyGenesis
Key People: LyGenesis